Pfizer, Inc.

Good day, everyone, and welcome to Pfizer's fourth quarter 2020 earnings conference call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chuck Triano, Senior Vice President of Investor Relations. Please go ahead, sir.

Thank you, operator. Good morning, everyone, and thanks for joining us today to review Pfizer's fourth quarter and full year 2020 financial results. our 2021 financial guidance, as well as other relevant business topics. I'm joined today as usual by our Chairman and CEO, Dr. Albert Borla, Frank D'Amelio, our CFO, Michael Dolson, President of Worldwide Research, Development and Medical, Angela Wong, Group President, Biopharmaceuticals Group, John Young, our Chief Business Officer, and Doug Langler, General Counsel. The slides that will be presented on this call were posted to our website earlier this morning and are available at Pfizer.com forward slash investors.

If you don't have $5,000 in your account, then you can skip this ad. I'm serious. If you don't have $5,000 in your account, then these strategies won't work for you.